Effectiveness and Safety of Optical Coherence Tomography- Guided PCI in Indian Patients with Complex Lesions- A Multicenter, Prospective Registry

Dr Praveen Chandra0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients of either sex aged 95 years > 18 years
•2. Patients willing to sign the informed consent form
•3. Patients scheduled for a clinically indicated PCI procedure, meeting the below criteria:
•Medically treated diabetes mellitus, AND/OR
•(i) Angiographically-detected high risk lesions, with at least one target lesion in the planned target vessel, and meeting the below criteria:
•Target lesion is the culprit lesion responsible for either NSTEMI, or STEMI >24 hours from the onset of ischemic symptoms.
•(ii)Long or multiple lesions (defined as intended total stent length in any single target vessel H28 mm)
•(iii)Bifurcation lesion with side branch H2.5 mm by visual estimation, intended to be treated with planned two-stent strategy (stenting in both the main branch and side branch)
•(iv) Angiographic severe calcification (defined as angiographically visible calcification on both sides of the vessel wall in the absence of cardiac motion)
•(v)In-stent restenosis (all patterns, as long as the lesion is at or within the stent margin(s) and has an angiographically visually-assessed DS H70% or DS H50% with non-invasive or invasive evidence of ischemia)

•1.Patients unwilling to sign informed consent
•2.Patients with bypass graft stenoses
•3.Patients with renal insufficiency (estimated glomerular filtration rate <50 mL/min/m2) or any other severe medical condition interfering with patientsâ?? safety or study results
•4. Patients with contraindications to dual-antiplatelet therapy up to 1 year
•5.Patients with other comorbidities that may limit life expectancy to less than one year

发起方

Dr Praveen Chandra